TruBridge Inc (TBRG) FinancialsTBRGFinancialTruBridge Inc

TruBridge Inc (TBRG) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Financial Health, accounting for 61.8% of total sales, equivalent to $53.27M. Another important revenue stream is Patient Care. Understanding this composition is critical for investors evaluating how TBRG navigates market cycles within the Advanced Medical Equipment & Technology industry.

Evaluating the bottom line, TruBridge Inc maintains a gross margin of 47.59%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 9.21%, while the net margin is 0.59%. These profitability ratios, combined with a Return on Equity (ROE) of 2.45%, provide a clear picture of how effectively TBRG converts its operational activities into shareholder value.

In the context of the broader market, TBRG competes directly with industry leaders such as ALHC and OSCR. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, TBRG's gross margin of 47.59% stands against ALHC's 12.96% and OSCR's N/A. Such benchmarking helps identify whether TruBridge Inc is trading at a premium or discount relative to its financial performance.

No financial data available for the latest quarter. However, previous reports indicate modest revenue growth and favorable EBITDA, though overshadowed by strategic reviews and legal issues.